P39. Teriparatide treatment improves bone quality in the lumbar spine out of proportion to DEXA changes
Anthony L. Mikula, MD1; Jeffery D. St. Jeor, BS2; Jeremy L. Fogelson, MD1; Annalise N. Larson, MD1; Ahmad N. Nassr, MD3; Brett A. Freedman, MD1; Arjun S. Sebastian, MD, MSc1; Bradford L. Currier, MD1; Mohamad Bydon, MD1; Michael J. Yaszemski, MD, PhD2; Benjamin D. Elder, MD, PhD2
1Mayo Clinic, Rochester, MN, US; 2Rochester, MN, US; 3Mayo Clinic Department of Orthopedic Surgery, Rochester, MN, US
FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
P40. Teriparatide treatment improves bone quality in the vertebral body out of proportion to the pedicles and lamina of the lumbosacral spine as measured by Hounsfield units
Anthony L. Mikula, MD1; Ryan M. Naylor, MD, PhD2; Jeffery D. St. Jeor, BS2; Jeremy L. Fogelson, MD1; Annalise N. Larson, MD1; Ahmad N. Nassr, MD3; Brett A. Freedman, MD1; Arjun S. Sebastian, MD, MSc1; Bradford L. Currier, MD1; Mohamad Bydon, MD1; Michael J. Yaszemski, MD, PhD2; Benjamin D. Elder, MD, PhD2
1Mayo Clinic, Rochester, MN, US; 2Rochester, MN, US; 3Mayo Clinic Department of Orthopedic Surgery, Rochester, MN, US
FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.